High Quality and Trustworthy Medical Insurance
The hospital focuses closely on the entire life, life cycle, and process of women and children Building a maternal and child health service system of "being able to carry on, being able to stay, having a smooth birth, being well raised, and living a healthy life"
Ranjiaba Campus in Liangjiang New District
As a critical care center for pregnant and postpartum women and critical care center for newborns in Chongqing, it manages over 16000 high-risk pregnant and postpartum women and over 5000 high-risk newborns annually.
Mainly engaged in gynecological, obstetric, and pediatric medical and health related businesses, it is in a leading position in the western region in terms of perinatal health services, treatment of newborns (extremely low birth weight infants, extremely premature infants), prevention and treatment of cervical diseases, diagnosis and treatment of female pelvic floor and urinary diseases, diagnosis and treatment of infertility, pre pregnancy eugenics examination, maternal and child health epidemiological investigation, pharmaceutical services, etc. The intrauterine treatment technology for fetuses has reached the leading level both domestically and internationally.
Qixinggang Campus in Yuzhong Distinct
From 2017 to 2023, reproductive medicine has been ranked in the Fudan University China Hospital Specialty Reputation Ranking for seven consecutive years Ranked 7th (first in the West).
Mainly engaged in human assisted reproductive related businesses, it is the birthplace of the first "test tube baby" in western China, the first reproductive center approved by the former Ministry of Health to carry out human assisted reproductive technology, a training base for human assisted reproductive technology (only our hospital is a specialized hospital), an academician workstation for innovative research in reproductive medicine, Chongqing Key Laboratory of Human Embryo Engineering and Precision Medicine, Chongqing Clinical Research Center for Reproductive Medicine, Chongqing Center for Assisted Reproductive Medicine, and Chongqing Center for Infertility Diagnosis, Treatment, and Fertility Preservation Quality Control.
As of the end of 2024, a total of over 78000 "test tube babies" have been born, and the clinical pregnancy rate has exceeded 60% for several consecutive years, which is at the leading level in China and higher than the same period in Europe and America.